Items Tagged ‘Dr. Lin’
November 9, 2017
CAR T-Cell Therapy for Relapsed Non-Hodgkin Lymphoma
This story first appeared on the Mayo Clinic News Network. Mayo Clinic announced recently that its Rochester campus is one of 16 cancer centers nationally selected to provide chimeric antigen receptor T-cell therapy (CAR T-cell therapy) for adults with B-cell non-Hodgkin lymphoma who have not responded to, or have relapsed, after two or more lines of treatment. The therapy, […]
Tags: axicabtagene ciloleucel, B-cell non-Hodgkin lymphoma, Dr. Lin, Dr. Yi Lin, Mayo Clinic CAR T-cell therapy, Medical Research, Minnesota News Releases, News Releases, Non-Hodgkin Lymphoma, regenerative immunotherapy, Yescarta, Yi Lin